Medical Conditions Drug Efficacy Anxiety Disorders Disease Management Health Communication Molecular Biology Food Safety Clinical Studies Medical Research Health Awareness
The FDA cited ADEPT Phase 2/3 trial data showing sustained remission alongside reduced corticosteroid exposure in elderly patients.